Logo.jpg
Biofrontera reports preliminary approximate revenues for the month of September 2021
01. Oktober 2021 07:44 ET | Biofrontera AG
Leverkusen, Germany, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...
Logo.jpg
Biofrontera reports Q1 2021 financial results
11. Mai 2021 10:41 ET | Biofrontera AG
Leverkusen, Germany, May 11, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
logo.jpg
Biofrontera announces conference call to be held on May 20, 2020 to discuss first quarter 2020 financial results
12. Mai 2020 11:00 ET | Biofrontera AG
Leverkusen, Germany, May 12, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
logo.jpg
Organizational restructuring of Biofrontera and resignation of Chief Commercial Officer Christoph Dünwald
31. Januar 2020 11:38 ET | Biofrontera AG
Leverkusen, Germany, Jan. 31, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced today that...
Logo_Biofrontera_AG.png
Biofrontera to participate at the Lake Street Capital Markets 2019 Best Ideas Growth (BIG) Conference
05. September 2019 11:45 ET | Biofrontera AG
Leverkusen, Germany, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be...
Logo_Biofrontera_AG.png
Biofrontera Announces Conference Call on August 27, 2019 to Discuss Half-year 2019 Financial Results
14. August 2019 05:30 ET | Biofrontera AG
Leverkusen, Germany, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
Logo_Biofrontera_AG.png
Biofrontera nominates new candidate for the Supervisory Board
04. Juni 2019 10:00 ET | Biofrontera AG
Leverkusen, Germany, June 04, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that...
Logo_Biofrontera_AG.png
Biofrontera to present at the Baader Investment Conference
19. September 2018 04:03 ET | Biofrontera AG
Leverkusen, Germany, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be...